BCG vs COVID19
We are travelling with SARS CoV2 for over a year now and some respite still elusive. Many have lost their life to this Infection globally. But interestingly, the advanced world countries are having more fatality than Underdeveloped Countries and Developing Countries.
Ashish Kamat was among the first in the world to suggest that BCG could be protective against COVI19 and its severity. He along with Paul Hegarty suggested that ‘BCG Vaccination may be Protective against COVID19’ even at the beginning of the Pandemic but it fell on relatively deaf ears over the ensuing months (PDF provided).
Elsayed Desouky (2021) addressed this issue of ‘BCG vs COVID19 and its Impact on Urology’ which is worth a read.
Héctor Gallegos, Ignacio F. San Francisco* et al (2021) published on ‘Protective role of intravesical BCG in COVID-19 severity’. It would be worthwhile if some of us could look at this aspect as whether how many who had Intravesical therapy for NMIBC developed COVID19.
The article from Prasanta Raghab Mohapatra* et al (2021) on ‘BCG Vaccination Induced Protection from COVID19’ is the most useful as regards we Indians are concerned.
This article addresses the Indian Scenario of COVID19 and how as a developing nation we are able to tackle it. It appears that BCG given to all Indians (that is the claim) born post 1948 may have a leading role in lessened mortality when compared to developed countries where use of BCG is not common.
I am sure these articles provided will give valuable information regarding COVID 19 and lessening the severity.
With warm Regards,
View DocumentView Document